A recent engadget article noted the first human Ebola vaccine to receive EU approval. Merck’s ERVEBO is the product of a unique collaboration between the Public Health Agency of Canada and the US Army over ten years ago. Merck acquired the rights to develop the vaccine after the 2014 Ebola outbreak in West Africa. On November 11th, the vaccine received a “conditional marketing authorization,” a distinction typically designated for medicines that treat unmet medical needs.
Quick Hits: EU Approves Human Ebola Vaccine
In a new first, Merck’s Ebola vaccine received a “conditional marketing authorization” from the European Union.
Nov 20, 2019
Fill out the form below to request more information about Quick Hits: EU Approves Human Ebola Vaccine
Recommended
Recommended
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Downloads
